PPARα is a key regulator of hepatic FGF21
Top Cited Papers
- 21 June 2007
- journal article
- Published by Elsevier
- Vol. 360 (2) , 437-440
- https://doi.org/10.1016/j.bbrc.2007.06.068
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in manJournal of Internal Medicine, 2006
- Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signalingJournal of Cellular Physiology, 2006
- Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling PathwaysDiabetes, 2006
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005
- Peroxisome proliferator-activated receptor a target genesCellular and Molecular Life Sciences, 2004
- Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart DiseaseDrugs, 2004
- Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice**This work was supported by grants from the Research Service of the Department of Veterans Affairs (to C.G. and K.R.F.), NIH Grant DK-49448 (to C.G.), and Merck Research Laboratories (to L.H.T. and K.N.).Endocrinology, 2000
- A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disordersProceedings of the National Academy of Sciences, 1999
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- [42] Use of human hepatocytes to study P450 gene inductionPublished by Elsevier ,1996